INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,000 | -22.2% | 16,446 | +3.5% | 0.00% | – |
| Q1 2018 | $9,000 | -30.8% | 15,894 | -2.0% | 0.00% | – |
| Q4 2017 | $13,000 | – | 16,214 | +135016.7% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 12 | -98.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 596 | -16.2% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 711 | +18.9% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 598 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -98.6% | 598 | -98.7% | 0.00% | – |
| Q2 2016 | $72,000 | +7100.0% | 46,098 | +7608.7% | 0.00% | – |
| Q1 2016 | $1,000 | -50.0% | 598 | -33.5% | 0.00% | – |
| Q4 2015 | $2,000 | 0.0% | 899 | -0.8% | 0.00% | – |
| Q3 2015 | $2,000 | +100.0% | 906 | +195.1% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 307 | -0.3% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 308 | +2.0% | 0.00% | – |
| Q4 2014 | $1,000 | – | 302 | +30100.0% | 0.00% | – |
| Q3 2014 | $0 | – | 1 | -98.6% | 0.00% | – |
| Q2 2014 | $0 | – | 69 | +1625.0% | 0.00% | – |
| Q1 2014 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q4 2013 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q3 2013 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST FOUNDATION ADVISORS | 274,592 | $686,000 | 0.04% |
| Argent Trust Co | 39,137 | $98,000 | 0.04% |
| Acrospire Investment Management LLC | 10,777 | $27,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 20,412 | $51,000 | 0.00% |
| HL FINANCIAL SERVICES LLC | 33,000 | $83,000 | 0.00% |
| Advisor Group, Inc. | 30,067 | $75,000 | 0.00% |
| Financial Architects, Inc | 1,100 | $3,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 245,800 | $615,000 | 0.00% |
| DEUTSCHE BANK AG\ | 305,807 | $763,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 16 | $0 | 0.00% |